Company intelligence / Profile preview

Global Bioenergies

Évry, Île-de-France, Franceglobal-bioenergies.com ↗

Ownership: Private
Employees: ~61
Development stage: Commercial

Overview

Global Bioenergies has developed a proprietary synthetic biology platform that enables the conversion of renewable feedstocks—such as sugars or agricultural waste—into gaseous hydrocarbons like isobutene via fermentation. This technology provides an alternative to oil-derived chemicals used in fuels, plastics, elastomers, and cosmetics. The company has demonstrated successful pilot-scale production and operates demonstration plants in France and Germany. It has also established joint ventures to scale up commercial manufacturing.

Industry: Non-Drug Biotech

Partnerships

Cristal Union (joint venture partner for IBN-One plant in France)Audi AG (partnership on biofuel development from bio-isobutene)

Beyond the preview

Go deeper on Global Bioenergies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Global Bioenergies.

Explore the full profile